However, flecainide is a “CYP2D6 substrate drug” tagged with “Precautions.” The severity of other DDIs also varies; for example, the DDI severity of the direct renin inhibitor aliskiren varies according to diabetes status. Here, CYP2D6 is linked to diabetes mellitus.